BMS-488043

DB05532ExperimentalSmall molecule

BMS-488043 has been investigated as an anti-HIV agent.

Chemical structure of BMS-488043
Primary indication
Investigated for use/treatment in HIV infection.Curator reviewed
Formula / weight
C22H22N4O5 · 422.441 g/mol (avg)
Code names
BMS 043 · BMS-488043

Resolves to

Compound
UNIIMKS21EJ435CAS452296-83-2ChEMBLCHEMBL238103
Structure
InChIKeyDBPMWRYLTBNCCE-UHFFFAOYSA-NSMILESCOC1=C2C(NC=C2C(=O)C(=O)N2CCN(CC2)C(=O)C2=CC=CC=C2)=C(OC)N=C1
Targets
Q5NUL3FFAR4

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
14Drug interactionsStructured to mechanism, not free text
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with BMS-488043, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In